IGFBP2: a possible molecular link between liver, heart, and bloodstream during metabolic dysfunction-associated steatotic liver disease

IGFBP2: a possible molecular link between liver, heart, and bloodstream during metabolic dysfunction-associated steatotic liver disease

Introduction and Objectives: Metabolic dysfunction-associated steatotic liver disease (MASLD) is highly prevalent worldwide, the concomitant presence of fibrosis is considered the most important risk factor of cardiovascular death. IGFBP2 is expressed mainly in the liver and at very low levels in he...

Full description

Bibliographic Details
Main Authors: Miriam G. Bautista-Ubaldo, Gabriela Gutiérrez-Reyes, Ignacio González-Sánchez, Armando Pérez-Torres, Carolina Guzmán
Format: Article
Language:English
Published: Elsevier 2024-02-01
Series:Annals of Hepatology
Online Access:http://www.sciencedirect.com/science/article/pii/S1665268124002473

Internet

http://www.sciencedirect.com/science/article/pii/S1665268124002473

Similar Items